Skip to main content
. 2015 Feb 5;6(12):9999–10015. doi: 10.18632/oncotarget.3171

Table 1. Characteristics of patients and PDA tumor tissues.

No. Gender Age Grading Pre-treatment
T22 m 79 pT, pT3, pN1 (5/31), G3, R1 not evaluated
T29 m 77 pT3, N1, G2, R2 not evaluated
T30 f 40 pT3, pN1 (16/30), G2, R1 not evaluated
5008 m 64 T3, pN1, (19/55), G2, L1, V1, Pn1 No
5009 f 51 pT3, pN1, G3, R0 No
5026 m 74 pT3, pN1, (8/33), G3, L1, V1 No
5027 f 60 pT3, pN1, (2/24), V1, Pn1, G2, R1 No
5031 m 60 pT3, pN1, (4/35), L1, V1, Pn1, G3, R1 No
5024 f 61 pT3, pN1, (27/37), L1, Pn1, G3, R1 No
4941 m 58 pT3, pN1, (9/21), Pn1, L1, G3, R1 ASA
4911 m 68 pT3, pN1, (10/22), G3, R1 ASA
4730 m 76 pT3, pN1, (5/22), L1, G2 ASA
4710 m 73 pT3, pN1, (2/35), L1, V0, PN1 ASA
4630 f 68 pT3, pN1, 82/25), G2, R0 ASA
4529 m 72 pT3, pN1, (4/61), L1, G3 ASA
4409 m 72 pT3, pN1, (9/18), G2 ASA
4945 m 63 ypT3, ypN0, (0/7), Pn1, R1 GEM
4912 m 54 ypT3, ypN1, yPn1, (1/18), R1 GEM
4827 m 56 ypT3, ypN0, (0/26), L1, Pn1, R1 GEM
4794 f 61 pT3, pN1, (1/10), G3, R1 GEM
4785 m 58 ypT3, ypN0, (0/15), R0 GEM
4318 m 63 ypT3, ypN0, (0/11), G0 ASA + GEM
4151 m 62 ypT3, ypN1, (1/23) ASA + GEM
3738 f 71 ypT3, ypN0 (0/13) ASA + GEM

f: Female; m: Male; IPMN: Intraductal papillary mucinous carcinoma; Tis: Carcinoma in situ, includes PanIN-3c; T1: Tumor limited to the pancreas, 2 cm or less in greatest dimension; T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension; T3: Tumor extending beyond the pancreas; T4: Tumor involving the coeliac axis or the superior mesenteric artery; N0: No regional lymph node metastasis; N1: Regional lymph node metastasis; Borderline: Between benign and malignant; M0: No distant metastasis; M1: Distant metastasis; G1: Well-differentiated; G2: Moderately differentiated; G3: Poorly differentiated.